Author [ Title] Type Year
Filters: Author is Ma, Qingyong [Clear All Filters]
Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Biomed Pharmacother. 2022;148:112713.
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif. 2018:e12514.
Resveratrol in the treatment of pancreatic cancer. Ann N Y Acad Sci. 2015.